Nanoenabled Intracellular Calcium Bursting for Safe and Efficient Reversal of Drug Resistance in Tumor Cells
Related Experiment Video
Updated: Dec 5, 2025

Simultaneous Measurement of Mitochondrial Calcium and Mitochondrial Membrane Potential in Live Cells by Fluorescent Microscopy
Published on: January 24, 2017
Junjie Liu1,2,3, Chunyu Zhu1, Lihua Xu1
1School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China.
Abstract:
Multidrug resistance (MDR) of a tumor is the main cause of failure of clinical chemotherapy. Herein, we report a simple, yet versatile, tumor-targeting "calcium ion nanogenerator" (TCaNG) to reverse drug resistance by inducing intracellular Ca2+ bursting. Consequently, the TCaNG could induce Ca2+ bursting in acidic lysosomes of tumor cells and then reverse drug resistance according to the following mechanisms: (i) Ca2+ specifically accumulates in mitochondria, suppressing cellular respiration and relieving tumor hypoxia, thus inhibiting P-glycoprotein biosynthesis by downregulating HIF-1α expression. (ii) Ca2+-bursting-induced respiratory depression blocks intracellular ATP production, which further leads to the P-gp incompetence. As a result, the TCaNG could decrease the IC50 of DOX to MCF-7/ADR cells by approximately 30 times and reduce the proliferation of drug-resistant tumors by approximately 13 times without obvious side effects. This simple, safe, and effective "Ca2+ bursting" strategy holds the potential for clinical application in tumor treatment.
Insights
This study introduces a novel tumor-targeting calcium ion nanogenerator (TCaNG) to overcome multidrug resistance (MDR) in cancer. TCaNG induces calcium ion bursting, effectively reversing chemotherapy resistance and inhibiting tumor growth.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Oncology
Background:
- Multidrug resistance (MDR) is a major obstacle in clinical chemotherapy, leading to treatment failure.
- Tumor cells often develop resistance through mechanisms like P-glycoprotein (P-gp) overexpression.
- Novel strategies are needed to overcome MDR and improve chemotherapeutic efficacy.
Purpose of the Study:
- To develop a tumor-targeting "calcium ion nanogenerator" (TCaNG) capable of reversing MDR.
- To investigate the mechanisms by which TCaNG overcomes drug resistance.
- To evaluate the efficacy and safety of TCaNG in preclinical models.
Main Methods:
- Design and synthesis of a tumor-targeting calcium ion nanogenerator (TCaNG).
- Induction of intracellular calcium ion (Ca2+) bursting in acidic tumor lysosomes.
- Assessment of TCaNG's impact on mitochondrial respiration, ATP production, and P-gp expression.
- Evaluation of TCaNG's ability to reverse doxorubicin (DOX) resistance in MCF-7/ADR cells and inhibit drug-resistant tumor proliferation.
Main Results:
- TCaNG successfully induced Ca2+ bursting in acidic tumor lysosomes.
- Ca2+ accumulation in mitochondria suppressed respiration, reduced tumor hypoxia, and downregulated HIF-1α expression, inhibiting P-gp biosynthesis.
- ATP production was blocked by Ca2+-induced respiratory depression, leading to P-gp incompetence.
- TCaNG decreased the IC50 of DOX to MCF-7/ADR cells by approximately 30-fold and reduced tumor proliferation by approximately 13-fold with minimal side effects.
Conclusions:
- The TCaNG is a simple, versatile, and effective tool for reversing multidrug resistance in tumors.
- The "Ca2+ bursting" strategy offers a promising approach for enhancing chemotherapy efficacy.
- TCaNG demonstrates potential for clinical translation in cancer treatment.
More Related Videos
Related Concept Videos
Drugs that Stabilize Microtubules
Drugs that Destabilize Microtubules
Treatment Resistant Cancers
Targeted Cancer Therapies
There are several types of targeted therapies against...

